Clinical trial
Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular…
NCT00061503 · Alcon Research, Industry · Completed
Key facts
| NCT number | NCT00061503 |
|---|---|
| Title | Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension |
| Official title | A Double-Masked, Placebo-Controlled, Paired Comparison Study of the Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension |
| Lead sponsor | Alcon Research, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Glaucoma, Ocular Hypertension |
| Intervention type | Drug |
| Interventions | Travoprost |
| Start date | Apr 1, 2003 |
| Primary completion | Mar 1, 2004 |
| Completion | Mar 1, 2004 |
| First posted | May 30, 2003 |
| Last update posted | Aug 5, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: